Novo Nordisk Aktie
46,55
EUR
-1,56
EUR
-3,23
%
45,99
EUR
-3,04
EUR
-6,20
%
Werbung
Novo Nordisk Aktie Analyse
07.05.20 | Novo Nordisk overweight | Barclays Capital | |
07.05.20 | Novo Nordisk Outperform | Credit Suisse Group | |
06.05.20 | Novo Nordisk buy | UBS AG | |
06.05.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
06.05.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
29.04.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
17.04.20 | Novo Nordisk buy | UBS AG | |
15.04.20 | Novo Nordisk buy | UBS AG | |
Werbung
|
|||
15.04.20 | Novo Nordisk Outperform | Bernstein Research | |
14.04.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
09.04.20 | Novo Nordisk overweight | Barclays Capital | |
07.04.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
24.03.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
23.03.20 | Novo Nordisk buy | UBS AG | |
18.03.20 | Novo Nordisk Outperform | Bernstein Research | |
17.03.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
17.03.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
17.03.20 | Novo Nordisk overweight | Barclays Capital | |
02.03.20 | Novo Nordisk overweight | Barclays Capital | |
25.02.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
06.02.20 | Novo Nordisk Outperform | Credit Suisse Group | |
06.02.20 | Novo Nordisk overweight | Barclays Capital | |
06.02.20 | Novo Nordisk Outperform | Bernstein Research | |
06.02.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
06.02.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
05.02.20 | Novo Nordisk overweight | Barclays Capital | |
05.02.20 | Novo Nordisk Outperform | Bernstein Research | |
05.02.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
31.01.20 | Novo Nordisk overweight | Barclays Capital | |
29.01.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
27.01.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
20.01.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
17.01.20 | Novo Nordisk overweight | Barclays Capital | |
17.01.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
16.01.20 | Novo Nordisk overweight | Barclays Capital | |
16.01.20 | Novo Nordisk Outperform | Credit Suisse Group | |
06.01.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
06.01.20 | Novo Nordisk kaufen | Bernstein Research | |
21.11.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
21.11.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
18.11.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
18.11.19 | Novo Nordisk overweight | Barclays Capital | |
06.11.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
04.11.19 | Novo Nordisk Outperform | Credit Suisse Group | |
04.11.19 | Novo Nordisk Outperform | Bernstein Research | |
04.11.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
01.11.19 | Novo Nordisk buy | UBS AG | |
01.11.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
28.10.19 | Novo Nordisk Outperform | Credit Suisse Group | |
21.10.19 | Novo Nordisk buy | UBS AG |
Werbung
Werbung